Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease

OBJECTIVE: To identify determinants for the discontinuation of non-ergoline dopamine agonist (DA) treatment in patients with Parkinson’s disease (PD) and to identify genetic determinants in genes encoding dopamine receptor (DR)D2 and DRD3 in a exploratory analysis. METHODS: Patients included were fi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Arbouw, Maurits E. L., Movig, Kris L. L., Egberts, Toine C. G., Poels, Petra J. E., van Vugt, Jeroen P. P., Wessels, Judith A. M., van der Straaten, R. J. H. M., Neef, Cees, Guchelaar, Henk-Jan
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2009
Assuntos:
Pharmacoepidemiology and Prescription
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2778789/
https://ncbi.nlm.nih.gov/pubmed/19669131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-009-0708-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados